Safety and Pharmacokinetic Study of NPT 2042 Soft-gelatin Capsules Administered Orally to Healthy Adult Subjects
Conditions: Epilepsy; Alzheimer Disease; Epilepsy Intractable Intervention: Drug: NPT 2042 (bumetanide analog) or Matching Placebo Sponsor: NeuroPro Therapeutics, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials